Helix BioPharma Corp. (TSE:HBP – Get Free Report) shares crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$0.93 and traded as high as C$0.98. Helix BioPharma shares last traded at C$0.98, with a volume of 5,000 shares changing hands.
Helix BioPharma Stock Up 5.4 %
The company has a market capitalization of C$51.96 million, a PE ratio of -1.03 and a beta of -0.84. The stock has a 50-day moving average of C$0.93 and a 200 day moving average of C$0.95.
About Helix BioPharma
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.
Recommended Stories
- Five stocks we like better than Helix BioPharma
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Helix BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helix BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
